Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

$24.99

Price to Sales (P/S)
since 2005

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Abbott Laboratories, P/S, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$

2 Data adjusted for splits and stock dividends.

3 Closing price as at the filing date of Abbott Laboratories Annual Report.


The financial data reveals several notable trends over the analyzed periods. The share price exhibited fluctuations but generally demonstrated an upward trajectory from 2006 to 2025. Initial moderate increases were observed until 2008, followed by a decline in 2009 and 2011. Subsequently, the share price experienced significant recovery and growth, reaching a peak in the early 2020s with intermittent minor corrections.

Sales per share showed a generally positive trend with some variability. From 2006 through 2013, sales per share increased steadily, although a marked dip occurred during 2013 and maintained lower levels through 2017. After this period, sales per share resumed growth, peaking again in the early 2020s before slightly retracting by 2024, then recovering slightly in 2025.

The Price-to-Sales (P/S) ratio displayed considerable variability across the years. Starting relatively high in 2006, the ratio saw a decline reaching its lowest in 2013, coinciding with a dip in share price and sales per share. From 2013 onwards, the P/S ratio increased substantially, peaking sharply around 2021, which suggests a higher valuation relative to sales during this period. Although some fluctuations occurred thereafter, the ratio remained elevated compared to the earlier years, reflecting potentially increased market optimism or expectations of future growth.

Share Price
Fluctuated with declines in 2009 and 2011, followed by substantial growth peaking around 2021, ending at a higher value in 2025 than in 2006.
Sales per Share
Displayed a steady increase through 2013, interrupted by a downturn through 2017, then resumed an upward trend, peaking in the early 2020s before a minor decrease and partial recovery.
Price-to-Sales Ratio
Started high in 2006, dipped sharply to its lowest in 2013, then rose significantly, peaking around 2021, suggesting increasing market valuation relative to sales over the last decade.

Overall, the data indicates periods of volatility and recovery, with the most recent years characterized by stronger market valuation metrics alongside robust sales per share performance. This suggests improved investor confidence and potential enhancement in the company’s profitability or growth outlook.


Comparison to Competitors

Abbott Laboratories, P/S, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Sector (Health Care Equipment & Services)

Abbott Laboratories, P/S, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Industry (Health Care)